12 Health Care Stocks Moving In Friday's Pre-Market Session
I'm LongbridgeAI, I can summarize articles.In Friday's pre-market session, several healthcare stocks showed significant movement. Gainers included Immuron (up 64.9%), Akanda (up 27.52%), Niki BioSolutions (up 15.66%), GridAI Technologies (up 12.79%), Artelo Biosciences (up 11.4%), and XORTX Therapeutics (up 11.16%). Conversely, losers featured BioXcel Therapeutics (down 19.1%), Dogwood Therapeutics (down 9.75%), Gelteq (down 9.5%), Aethlon Medical (down 9.33%), bioAffinity Technologies (down 9.24%), and Cyclerion Therapeutics (down 6.05%).
Gainers
- Immuron (NASDAQ:IMRN) stock increased by 64.9% to $1.83 during Friday's pre-market session. The company's market cap stands at $8.9 million.
- Akanda (NASDAQ:AKAN) shares increased by 27.52% to $4.68. The company's market cap stands at $1.9 million.
- Niki BioSolutions (NASDAQ:NIKI) stock rose 15.66% to $7.53. The market value of their outstanding shares is at $5.3 million.
- GridAI Technologies (NASDAQ:GRDX) shares moved upwards by 12.79% to $3.35. The market value of their outstanding shares is at $21.1 million.
- Artelo Biosciences (NASDAQ:ARTL) shares rose 11.4% to $6.93. The market value of their outstanding shares is at $3.4 million.
- XORTX Therapeutics (NASDAQ:XRTX) shares increased by 11.16% to $2.39. The company's market cap stands at $3.9 million.
Losers
- BioXcel Therapeutics (NASDAQ:BTAI) stock decreased by 19.1% to $0.1 during Friday's pre-market session. The market value of their outstanding shares is at $3.6 million.
- Dogwood Therapeutics (NASDAQ:DWTX) shares decreased by 9.75% to $2.13. The company's market cap stands at $80.2 million.
- Gelteq (NASDAQ:GELS) stock fell 9.5% to $0.81. The company's market cap stands at $9.5 million.
- Aethlon Medical (NASDAQ:AEMD) stock decreased by 9.33% to $1.75. The company's market cap stands at $1.3 million.
- bioAffinity Technologies (NASDAQ:BIAF) shares fell 9.24% to $11.6. The market value of their outstanding shares is at $7.5 million.
- Cyclerion Therapeutics (NASDAQ:CYCN) shares declined by 6.05% to $4.66. The market value of their outstanding shares is at $23.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.